Your activity: 28 p.v.
your limit has been reached. plz Donate us to allow your ip full access, Email: sshnevis@outlook.com

Overview of benign lesions of the skin

Overview of benign lesions of the skin
Author:
Adam O Goldstein, MD, MPH
Section Editor:
Robert P Dellavalle, MD, PhD, MSPH
Deputy Editor:
Rosamaria Corona, MD, DSc
Literature review current through: Nov 2022. | This topic last updated: Jun 16, 2022.

INTRODUCTION — Individuals may acquire a multitude of benign skin lesions over the course of a lifetime. Many of these lesions are easily visible, and patients often ask clinicians to confirm that new growths on the skin are benign.

The clinical features, diagnosis, and treatment of some acquired, benign skin lesions will be discussed here. Benign lesions in the newborn and infant are discussed separately. Malignant neoplasms of the skin are also discussed separately.

(See "Skin lesions in the newborn and infant".)

(See "Epidemiology, pathogenesis, clinical features, and diagnosis of basal cell carcinoma".)

(See "Cutaneous squamous cell carcinoma (cSCC): Clinical features and diagnosis".)

(See "Melanoma: Clinical features and diagnosis".)

APPROACH TO DIAGNOSIS — Most benign skin lesions are diagnosed based on clinical appearance (morphology, distribution) and history. (See "Approach to the clinical dermatologic diagnosis".)

Dermoscopy, a skin examination technique performed with a handheld instrument called a dermatoscope that allows the visualization of subsurface skin structures, is a helpful adjunct to the clinical examination of a variety of pigmented and nonpigmented lesions. (See "Dermoscopic evaluation of skin lesions".)

If the diagnosis of a lesion is uncertain or if a lesion has exhibited unexpected or rapid changes in appearance or symptoms, a diagnostic procedure (eg, biopsy, excision) is indicated for a precise diagnosis. (See "Skin biopsy techniques".)

DERMAL TUMORS

Acrochordon (skin tag) — Acrochordon, commonly known as a skin tag, is an outgrowth of normal skin. It appears as a pedunculated lesion on a narrow stalk (picture 1A-E).

Acrochordons are common in adult individuals, and the risk of developing them increases with age [1]. They are frequently seen in obese patients and in patients with diabetes mellitus [2,3]. Observational studies suggest that acrochordons may be a skin sign of insulin resistance and metabolic syndrome [4-6] (see "Insulin resistance: Definition and clinical spectrum"). Skin tags also appear with increased frequency during the second trimester of pregnancy and may regress postpartum [7].

Acrochordons usually occur in sites of friction, particularly the axilla, neck, inframammary, and inguinal regions. They become symptomatic when traumatized (eg, caught on jewelry, rubbed by clothing). An infarcted acrochordon, resulting from torsion of its peduncle, appears as a red or black lesion (picture 1F).

Perianal skin tags are common in patients with Crohn's disease [8]. Acrochordons, together with fibrofolliculomas and trichodiscomas, are seen in Birt-Hogg-Dubé syndrome, an inherited condition characterized by cutaneous adnexal tumors, lung cysts, spontaneous pneumothorax, and increased risk of kidney cancer [9] (see "Perianal Crohn disease" and "Birt-Hogg-Dubé syndrome"):

Diagnosis – The diagnosis of acrochordons is usually based upon clinical appearance. They must be differentiated from neurofibromas, which are usually larger and firmer than acrochordons (picture 2), and from pedunculated dermal nevus (picture 3). The latter sometimes can only be differentiated histologically. (See "Neurofibromatosis type 1 (NF1): Pathogenesis, clinical features, and diagnosis", section on 'Peripheral neurofibromas'.)

Treatment – Treatment is indicated if lesions are irritating or the patient desires removal for cosmetic reasons. Local anesthesia with 1% lidocaine with epinephrine may be required in larger lesions. Treatment options include (see "Office-based dermatologic diagnostic procedures"):

Removal with forceps and fine-grade scissors; larger lesions may require suturing.

Cryosurgery with liquid nitrogen.

Electrodesiccation.

Lesions often bleed freely after surgical removal. Thus, aluminum chloride, silver nitrate sticks, or electrosurgery should be readily available for coagulation; however, silver nitrate may cause permanent skin pigmentation [10]. Lesions are unlikely to recur after removal, but new lesions develop in predisposed skin areas.

Dermatofibroma — Dermatofibroma, also called benign fibrous histiocytoma, is one of the most common cutaneous soft-tissue lesions. It represents a benign dermal proliferation of fibroblasts. The pathogenesis is unknown; sometimes, they may occur as a result of trauma or insect bites.

Clinical features — Dermatofibroma typically presents as a solitary, firm, often hyperpigmented nodule 0.3 to 1 cm in diameter (picture 4A-B), but giant lesions larger than 3 cm in diameter have been described [11,12]. Dermatofibromas occur most often in adults and are most commonly located on the lower extremities. Lesions are usually asymptomatic but may be pruritic. On palpations, dermatofibromas are fixed to the subcutaneous tissues and characteristically dimple when pinched (picture 4C).

Multiple "eruptive" dermatofibromas (picture 5) have been described in patients with autoimmune diseases receiving immunosuppressive therapies, in patients with HIV infection, and in pregnant women [13-15]. Rare familial cases inherited in an autosomal dominant pattern have also been reported [16].

Rare variants

Metastasizing dermatofibroma — Metastasizing, benign dermatofibromas are exceedingly rare. They are generally larger than common dermatofibromas (>3 cm). Morphologically, they may show features of cellular, aneurysmal, or atypical dermatofibroma; increased number of mitoses; and extension into the subcutis [17]. Local recurrence is common; the most common metastatic sites are the lungs and lymph nodes [18].

Multiple clustered dermatofibroma — Multiple clustered dermatofibroma is an extremely rare variant of dermatofibroma. It presents as a plaque composed of multiple (>15) individual reddish to hyperpigmented papules, most often located on the lower extremities [19]. It is usually seen in children and young adults and may be congenital or eruptive [20]. The differential diagnosis includes dermatofibrosarcoma protuberans and atypical fibroxanthoma. (See "Dermatofibrosarcoma protuberans: Epidemiology, pathogenesis, clinical presentation, diagnosis, and staging" and "Atypical fibroxanthoma".)

Diagnosis — Diagnosis is usually based upon clinical appearance and history. If the lesion is longstanding, it should have no history of rapid change. Examination with a dermatoscope shows a peripheral, delicate pigment network with a central, scar-like area (picture 6). (See "Dermoscopic evaluation of skin lesions", section on 'First step: Melanocytic versus nonmelanocytic'.)

A skin biopsy may be required if the diagnosis is uncertain.

Histopathology — Histologically, dermatofibromas are composed of uniform spindle cells arranged in elongated fascicles parallel to the epidermis. Dermatofibroma stains positive for factor XIIIa and vimentin, but, in contrast with dermatofibrosarcoma protuberans, are CD34 negative.

Histologic variants — Multiple uncommon histologic variants of dermatofibroma exist, including [17,21,22]:

Atypical dermatofibroma – Atypical dermatofibroma, also called atypical fibrous histiocytoma or dermatofibroma with monster cells, is a rare variant of dermatofibroma characterized histologically by a proliferation of pleomorphic cells with large, bizarre, hyperchromatic nuclei in a background of typical spindle cells arranged around thick collagen bundles [21].

Cellular dermatofibroma – Cellular benign dermatofibroma, also called cellular fibrous histiocytoma, is characterized by a dense proliferation of fibrohistiocytic cells that may extend to the subcutis and show normal mitotic figures. A recurrence rate of 10 percent has been reported for lesions that were excised with involved margins [23].

Epithelioid dermatofibroma – The epithelioid variant is composed of large, angulated, epithelioid cells that resemble the cells of intradermal Spitz nevus. (See "Spitz nevus and atypical Spitz tumors".)

Aneurysmal dermatofibroma – Aneurysmal dermatofibromas are rare mesenchymal tumors arising from fibroblast and histiocytic cells in the dermal layer of the skin. They present as blue, red, or purple papules, usually located on the lower extremities. Histologically, aneurysmal dermatofibromas consist of spindle-like cells with interspersed collagen bundles and typically show blood-filled tissue spaces and hemosiderin deposition in the surrounding cells. These lesions are frequently clinically misdiagnosed as vascular lesions.

Hemosiderotic dermatofibroma – Hemosiderotic fibrous histiocytomas, composed of small blood vessels and extravasated red cells with hemosiderin deposition, may be related to aneurysmal dermatofibromas. They may be mistaken for a melanoma or other pigmented lesions [24].

Differential diagnosis — The differential diagnosis of dermatofibroma includes a wide range of skin lesions. Examples of lesions that may resemble dermatofibroma are:

Intradermal nevi – Intradermal nevi are usually softer than dermatofibromas and do not dimple when pinched (picture 3). (See "Acquired melanocytic nevi (moles)".)

Basal cell carcinoma – Nodular basal cell carcinomas usually have a pearly or translucent quality and telangiectasias are frequently seen within the lesion (picture 7). (See "Epidemiology, pathogenesis, clinical features, and diagnosis of basal cell carcinoma".)

Keratoacanthoma – Keratoacanthomas are characterized by rapid growth and typically show a central keratinous plug (picture 8). (See "Keratoacanthoma: Epidemiology, risk factors, and diagnosis".)

Dermatofibrosarcoma protuberans – An early lesion of dermatofibrosarcoma protuberans may present as an indurated skin-colored nodule that grows slowly over months to years (picture 9). Histopathologic examination is necessary for the correct diagnosis. (See "Dermatofibrosarcoma protuberans: Epidemiology, pathogenesis, clinical presentation, diagnosis, and staging".)

Treatment — Usually, no treatment is required unless the lesion is symptomatic. Excision for histopathologic examination is indicated for any changing or bleeding lesion or when the lesion is suspicious for malignancy. Atypical variants are more likely to recur and, rarely, may metastasize. Therefore, complete excision is recommended to confirm clear margins [21]. Some patients may require excision for cosmetic reasons. However, patients should be warned that the scar can look worse than the initial lesion, especially on the lower extremities.

Liquid nitrogen cryotherapy may be an alternative treatment option for lesions that protrude above the skin surface and are irritated from repeated trauma. Resolution or flattening of lesions with good cosmetic results has been reported [25]. (See "Minor dermatologic procedures", section on 'Cryotherapy (cryosurgery)'.)

Cutaneous neurofibroma — Cutaneous neurofibroma is a benign nerve sheath tumor composed of cells of neuromesenchymal origin, including Schwann cells, fibroblasts, perineurial cells, and mast cells. Multiple cutaneous neurofibromas and their variants (ie, plexiform, dermal) may occur in the setting of neurofibromatosis. (See "Neurofibromatosis type 1 (NF1): Pathogenesis, clinical features, and diagnosis", section on 'Peripheral neurofibromas'.)

Most commonly, cutaneous neurofibroma occurs as a sporadic, solitary lesion in healthy adults. It typically presents as a asymptomatic, soft, skin-colored or hyperpigmented papule or nodule <2 cm in diameter (picture 2). Applying direct pressure to some neurofibromas may make them seem to retract into the skin, a finding that has been described as the "button-hole" sign.

The clinical differential diagnosis for neurofibromas often includes dermal melanocytic nevi (picture 3) and acrochordon (picture 1A). (See "Acquired melanocytic nevi (moles)" and 'Acrochordon (skin tag)' above.)

Treatment is not necessary for solitary cutaneous neurofibromas. Surgical excision can be used to remove lesions when the diagnosis is in question or when removal is desired due to discomfort or cosmetic concerns.

EPIDERMAL TUMORS

Seborrheic keratosis — Seborrheic keratosis is a common epidermal tumor consisting of a benign proliferation of immature keratinocytes [26]. It is most commonly seen in middle-aged individuals, but it can also develop in young adults. There is a genetic predisposition to develop a high number of seborrheic keratoses, although the precise inheritance pattern is unknown. The pathogenesis is incompletely understood. Evidence for a role of cumulative UV radiation exposure or human papillomavirus (HPV) infection is inconsistent [27]. Somatic activating mutations in the fibroblast growth factor receptor 3 (FGFR3) and PIK3CA oncogenes have been found in seborrheic keratoses, but their pathogenetic role is uncertain [28-31].

Clinical features — Seborrheic keratosis presents as a well-demarcated, round or oval lesion with a dull, verrucous surface and a typical stuck-on appearance (picture 10A-D). It is generally asymptomatic, but chronic irritation due to friction trauma may occasionally cause pruritus, pain, or bleeding. Seborrheic keratosis may vary in color, from skin colored to light brown, dark brown, or black.

The number of seborrheic keratoses can vary from an isolated lesion to literally hundreds. A "Christmas tree" pattern may be seen on the back, due to lesion distribution along the Blaschko lines (picture 11). The sign of Leser-Trélat, which refers to the sudden appearance of multiple seborrheic keratoses in association with skin tags and acanthosis nigricans, has been associated with a variety of malignancies, including gastrointestinal and lung cancers. Inflammation of preexisting seborrheic keratoses may occur during chemotherapy, in particular with cytarabine or docetaxel (pseudo-sign of Leser-Trélat) [32,33]. (See "Cutaneous manifestations of internal malignancy", section on 'Sign of Leser-Trélat' and "Cutaneous manifestations of internal malignancy", section on 'Acanthosis nigricans'.)

Clinicopathologic variants of seborrheic keratosis include dermatosis papulosa nigra (picture 12A-C), stucco keratosis (picture 13), large cell acanthoma (picture 14), clonal seborrheic keratosis, and irritated seborrheic keratosis. (See 'Dermatosis papulosa nigra' below.)

Diagnosis and differential diagnosis — The diagnosis of seborrheic keratosis is usually based on the clinical appearance of "stuck on," warty, well-circumscribed, often scaly hyperpigmented lesions located most commonly on the trunk, face, and upper extremities (picture 10A, 10E-F). Close inspection with a hand lens often will demonstrate the presence of horn cysts or dark keratin plugs (picture 15). Examination with a dermatoscope shows multiple milia cysts, comedo-like openings, and fissures and ridges forming a cerebriform pattern (picture 16).

Biopsy may be necessary if the diagnosis is uncertain and there is concern for malignancy. Rare cases of seborrheic keratoses with associated basal cell carcinomas or melanomas (collision tumors) have been reported [34-38]. (See "Office-based dermatologic diagnostic procedures" and "Skin biopsy techniques".)

Histologically, seborrheic keratosis typically shows a well-demarcated proliferation of keratinocytes, with characteristic small keratin-filled cysts. A dermal lymphocytic infiltrate is often present in inflamed or irritated lesions.

Seborrheic keratoses should be differentiated from other benign and malignant lesions, including:

Acrochordon (see 'Acrochordon (skin tag)' above)

Verruca vulgaris (see "Cutaneous warts (common, plantar, and flat warts)")

Epidermal nevus (see "Epidermal nevus and epidermal nevus syndrome")

Melanocytic nevus (see "Acquired melanocytic nevi (moles)")

Basal cell carcinoma (see "Epidemiology, pathogenesis, clinical features, and diagnosis of basal cell carcinoma")

Squamous cell carcinoma (see "Cutaneous squamous cell carcinoma (cSCC): Clinical features and diagnosis")

Melanoma (see "Melanoma: Clinical features and diagnosis")

It is important that lesions with atypical clinical and dermoscopic features (eg, large lesions, history of rapid change or growth, ulcerated lesions) be biopsied for histopathologic examination [39].

Treatment — Because seborrheic keratoses are benign and slow-growing lesions, treatment is generally not required. However, lesions that are symptomatic or that cause cosmetic concerns can be removed. Treatments commonly used in clinical practice include (see "Minor dermatologic procedures"):

Cryotherapy – Cryotherapy is the treatment most commonly used, particularly for flat or thin lesions. Cryotherapy should only be used if the clinical diagnosis is not in doubt.

Curettage/shave excision – Curettage or shave excision, with submission of specimen for pathology, can be performed with a no. 15 scalpel blade after anesthesia with 1% lidocaine.

Electrodesiccation – Electrodesiccation alone or followed by curettage usually requires anesthesia with 1% lidocaine.

A variety of lasers, including pulsed carbon dioxide (CO2) laser, erbium yttrium aluminium garnet (YAG) laser, 755 nm alexandrite laser, and 532 nm diode laser, have been also used for the treatment of seborrheic keratosis [40-42]. However, none of the above treatments has been adequately evaluated in randomized trials. The choice of therapy is generally based upon the lesion size and thickness, patient's skin type, and clinical experience.

In a small study of 25 patients, treatment of seborrheic keratoses with either cryotherapy or curettage with a no. 15 scalpel provided similar cosmetic improvement as rated by patients [43]. However, most patients preferred cryotherapy over curettage due to the minimal postoperative wound care required with cryotherapy.

Postinflammatory hypo- or hyperpigmentation and scarring may occur with healing. Postinflammatory hypopigmentation following cryotherapy is particularly frequent in individuals with dark skin. (See "Acquired hyperpigmentation disorders", section on 'Postinflammatory hyperpigmentation'.)

Dermatosis papulosa nigra — Dermatosis papulosa nigra (DPN) is characterized by the presence of multiple hyperpigmented papules measuring from 1 to 5 mm on the face of individuals with darker skin tones (picture 12A, 12D). There is a genetic predisposition to DPN, with over 50 percent of patients reporting the condition in other family members [44]. Typically, lesions are symmetrically distributed on the face; less frequently, they can occur on the neck and trunk.

Histologically, DPN lesions show acanthosis, papillomatosis, and hyperkeratosis, and are considered a variant of seborrheic keratosis. However, in contrast with seborrheic keratosis, horn pseudocysts are usually absent.

The treatment of dermatosis papulosa nigra may be particularly challenging, due to the high risk of posttreatment pigmentary alterations in patients with dark skin types. Treatment options include snip excision, curettage, electrodesiccation, and laser vaporization [45]. Light electrodesiccation using low power settings is most commonly used. The application of a petrolatum-based ointment after the procedure may alleviate subjective symptoms of burning and pain and promote healing [46].

Cryotherapy should be avoided, due to the high frequency of postinflammatory hypopigmentation in patients with dark skin.

APPENDAGEAL (ADNEXAL) TUMORS — Benign appendageal tumors are relatively uncommon neoplasms that exhibit morphologic eccrine, apocrine, follicular, or sebaceous differentiation (table 1). They typically present as pink, skin-colored, or slightly bluish papules or nodules ranging in size from a few millimeters to several centimeters (picture 17A-E).

Benign and malignant cutaneous adnexal tumors are discussed separately. (See "Cutaneous adnexal tumors".)

CYSTS — A cutaneous cyst is a sac-like lesion lined by an epithelium that presents as a dermal or subcutaneous papule or nodule. Several cyst subtypes can be distinguished based on the nature of the lining epithelium and cyst content. Common cutaneous cysts, including milia and epidermoid cysts, are lined by stratified squamous epithelium. Some cysts, including mucocele and digital myxoid cyst, are not lined by an epithelium.

Milium — Milia are minute subepidermal keratin cysts that arise from the pilosebaceous units or eccrine sweat ducts. They present as firm, white papules, 1 to 2 mm in diameter, most frequently located on the face (picture 18). Milia are common lesions; they occur at all ages and are a common finding in newborns.

In adults, when milia are small, they may at times be confused with other common lesions, such as flat warts or syringoma (picture 19) (see "Cutaneous adnexal tumors", section on 'Syringoma'). Milia are reported to fluoresce bright yellow under Wood's lamp, and this may be used in cases of diagnostic uncertainty [47]. (See "Skin lesions in the newborn and infant".)

Milia may develop spontaneously or as secondary lesions during the healing process of second-degree burns, blistering diseases (eg, epidermolysis bullosa, porphyria cutanea tarda), dermabrasion, and ablative laser resurfacing. They may also be an adverse effect of tyrosine kinase inhibitors [48]. The so-called "milia en plaque" is an unusual lesion consisting of a cluster of milia occurring on an erythematous and edematous base, typically located in the retroauricular area and associated with autoimmune skin disorders.

Histologically, the milial cyst consists of a wall of several layers of stratified squamous epithelium and a central keratinous material, similar to epidermoid cysts.

Milia can be treated for cosmetic reasons by incision of the overlying epidermis and expression of the content. Smaller lesions may respond to topical retinoids applied daily for several weeks. Recurrence is uncommon [49,50].

Epidermoid cyst

Clinical features — Epidermoid cyst, also called epidermal cyst, epidermal inclusion cyst, or, improperly, "sebaceous cyst," is the most common cutaneous cyst. It can occur anywhere on the body and typically presents as an asymptomatic, skin-colored dermal nodule (picture 20C), often with a clinically visible central punctum (picture 20A-B). The size ranges from a few millimeters to several centimeters in diameter. The cyst wall consists of normal stratified squamous epithelium derived from the follicular infundibulum.

Epidermoid cysts unusual in number and location (extremities rather than face, base of ears, and trunk) may be seen in the setting of Gardner syndrome, a rare, inherited condition characterized by familial adenomatous polyposis of the colon associated with a number of extracolonic abnormalities. (See "Gardner syndrome".)

Epidermoid cysts may be primary or may arise from the implantation of the follicular epithelium in the dermis, as a result of trauma, or from a comedo. Lesions may remain stable or progressively enlarge. Spontaneous inflammation and rupture can occur, with significant involvement of surrounding tissue (picture 21). There is no way to predict which lesions will remain quiescent and which will become larger or inflamed.

Epidermoid cysts may become secondarily infected by the normal skin flora. Infected, fluctuant cysts tend to be larger, more erythematous, and more painful than sterile, inflamed cysts, although an intense, inflammatory response to cyst rupture may also occur in the absence of infection.

Diagnosis and differential diagnosis — The diagnosis of epidermoid cyst is usually clinical, based upon the clinical appearance of a discrete cyst or nodule, often with a central punctum, that is freely movable on palpation (picture 20B-C). The diagnosis can be confirmed by histologic examination. The cyst wall consists of stratified squamous epithelium similar to skin surface or infundibulum of hair follicles. The cavity is filled with laminated layers of keratinous material. In ruptured cysts, a foreign-body inflammatory granulomatous reaction due to the release of the cyst content into the dermis may result in the formation of a keratin granuloma (picture 22).

The differential diagnosis of epidermoid cysts includes:

Pilar cysts (picture 27B) (see 'Pilar (trichilemmal) cysts' below).

Lipoma (picture 23A-B) (see 'Lipoma' below).

Pilomatricoma (picture 17B, 17F) (see "Cutaneous adnexal tumors", section on 'Pilomatricoma').

Abscess (see "Acute cellulitis and erysipelas in adults: Treatment").

Ganglion cysts (picture 24A-B) (see "Ganglion cysts of the wrist and hand", section on 'Definition').

Steatocystoma multiplex (see 'Steatocystoma multiplex' below).

Dermoid cyst – In infants and young children, a dermoid cyst is another possible confusing diagnosis. Dermoid cysts are congenital lesions that present as subcutaneous nodules seen along embryonic fusion lines on the face, scalp, and spine and contain epidermal and dermal tissues. The most common locations include the anterior fontanelle, the upper lateral region of the forehead near the eyebrow (picture 25), and the submental region. Nasal dermoids, resulting from congenital fusion abnormalities at the nasal root, present as noncompressible masses over the nasal dorsum with an associated midline pit or punctum (picture 26). (See "Cutaneous developmental anomalies in the newborn and infant" and "Congenital anomalies of the nose", section on 'Nasal dermoids'.)

Treatment — Treatment of stable, uninfected epidermoid cysts is not necessary, unless desired by the patient. Inflamed, ruptured cysts that are not infected may resolve spontaneously without therapy, although they tend to recur. Injection of triamcinolone acetonide (3 mg/mL for the face and 10 mg/mL for the trunk) into the inflamed lesion can hasten the resolution of inflammation and may prevent infection and the need for incision and drainage. Only small amounts (enough to slightly distend the cyst) should be injected, since injection of larger amounts can result in rupture and scarring. If the lesion is fluctuant, incision and drainage is indicated rather than injection.

Excision is best accomplished when the lesion is not inflamed; when the cyst is acutely inflamed the cyst wall is very friable, complete excision usually is not possible, and recurrence is likely. Thus, it is reasonable to wait until the inflammation has resolved before attempting excision. A description of cyst excision can be found separately. (See "Minor dermatologic procedures", section on 'Epidermoid cysts'.)

The punch incision technique and minimal incision technique are alternative methods to remove uncomplicated epidermoid cysts [51-54]. A small incision is made on the cyst with a no. 11 surgical blade or 4 mm punch; the cyst content is then expressed by exerting a vigorous lateral pressure on the cyst (figure 1). With this procedure, the cyst wall is usually released from the surrounding tissues and can be extracted through the small incision. The minimal incision technique provides better cosmetic results than the standard excision and is particularly useful for cysts in cosmetically sensitive areas. Recurrence rates of approximately <1 to 8 percent have been reported with the minimal incision technique [51,52,54].

Fluctuant cysts require incision with a no. 11 blade and drainage of the purulent material after anesthesia with 1% lidocaine. Anesthesia should be injected around the lesion rather than into the lesion in order to avoid rupturing the cyst wall with the pressure of the anesthetic agent. (See "Techniques for skin abscess drainage".)

The presence of significant surrounding cellulitis or cysts that have not responded to drainage may require oral antibiotic therapy, although in most cases the lesions are sterile. However, the drained contents should be sent for culture. Pending culture results, empiric antibiotic therapy can be started with agents active against methicillin-resistant Staphylococcus aureus (MRSA) in areas of high MRSA prevalence (table 2). (See "Acute cellulitis and erysipelas in adults: Treatment".)

Pilar (trichilemmal) cysts — A pilar cyst (trichilemmal cyst) resembles an epidermoid cyst, as it presents as a firm, slow-growing subcutaneous nodule. It is derived from the root sheath of the hair follicle and is most commonly located on the scalp (picture 27A-B). Pilar cysts can occur sporadically or in the setting of a hereditary predisposition with autosomal dominant transmission [55]. Patients with familial pilar cysts are often younger and often present with multiple lesions at the same time. Hereditary trichilemmal cysts appear to result from a two-hit mechanism involving germline and somatic variants of the phospholipase C Delta 1 gene (PLCD1) [56].

Removal of pilar cysts is usually easier than removing epidermoid cysts, since the cyst wall is firm and tends not to rupture as easily. Enucleated cysts typically appear as firm, smooth, white nodules. Histologic examination of the removed lesion can confirm the diagnosis.

Vellus hair cyst — Eruptive vellus hair cyst (EVHC) is a benign condition occurring in children and young adults, characterized by a sudden appearance of small, follicular, dome-shaped papules, usually on the trunk (picture 28) [57]. The disorder is due to a developmental abnormality of the vellus hair follicle at the infundibular level and may be inherited in an autosomal dominant fashion. The diagnosis is based upon the histologic finding of a cystic structure located in the mid-dermis lined by squamous epithelium containing laminated keratinous material and numerous vellus hairs.

EVHC are usually asymptomatic and may slowly regress over several years. However, patients may require treatment for cosmetic reasons. Treatment modalities include incision and extraction, carbon dioxide (CO2) laser or erbium-doped yttrium aluminium garnet (Er:YAG) laser vaporization, and topical retinoids [58-60].

Steatocystoma multiplex — Steatocystoma multiplex is an uncommon disorder characterized by multiple dermal, sebum-containing cysts measuring from less than 3 mm in diameter to 3 cm or more (picture 29) [61]. Lesions usually appear during adolescence or early adulthood and can occur anywhere on the body, including the scalp, intertriginous areas, and genitalia, but show a predilection for the chest.

Steatocystoma multiplex is caused by mutations in the KRT17 gene, which also cause a subtype of pachyonychia congenita [62], and is, in most cases, a sporadic disorder, although it may be inherited as an autosomal dominant trait (see "Pachyonychia congenita"). Histopathologically, lesions consist of dermal cyst lined by a thin wall of stratified squamous epithelium containing small sebaceous gland lobules and sebum.

Treatment is difficult, due to the high number of lesions. Options include surgical excision, incision and expression of the cyst content followed by extraction of the cyst wall, and carbon dioxide laser therapy [63-65].

Mucocele — A mucocele is a common cystic lesion most frequently found in the lower lip mucosa. It results from mucin leakage from a disrupted salivary duct, in most cases as a consequence of an intraoral trauma (eg, repetitive lip biting). They are variable in size, contain a gelatinous fluid, and typically appear as pink/blue, soft papules or nodules (picture 30).

Digital myxoid cyst — A digital myxoid cyst or myxoid pseudocyst (also called mucous or mucoid cyst) typically presents as a translucent nodule on the dorsum of the digit between the distal interphalangeal joint and the proximal nail fold (picture 31). It results from mucoid degeneration of the connective tissue and/or joint fluid leaking from an osteoarthritic distal interphalangeal joint by way of a communicating canal. The diagnosis and treatment of digital myxoid cysts are discussed separately. (See "Principles and overview of nail surgery", section on 'Digital myxoid cyst' and "Overview of nail disorders", section on 'Digital myxoid cyst or myxoid pseudocyst'.)

VASCULAR TUMORS

Infantile hemangioma — Infantile hemangiomas are benign tumors of vascular endothelium and the most common tumors of childhood (picture 32). The clinical presentation, diagnosis, and management of infantile hemangiomas are discussed separately. (See "Infantile hemangiomas: Epidemiology, pathogenesis, clinical features, and complications" and "Infantile hemangiomas: Evaluation and diagnosis" and "Infantile hemangiomas: Management".)

Cherry angioma — Cherry angiomas, also known as Campbell de Morgan spots, are mature capillary proliferations that are common in middle-aged and older adult patients. They tend to be less conspicuous in individuals with darker complexion. They usually occur as multiple lesions, most commonly on the trunk, and bleed profusely with any traumatic rupture. The pathogenesis is incompletely understood. Oncogenic mutations in GNAQ and GNA11, similar to those found in port wine stains and Sturge-Weber syndrome, have been found in 50 percent of tissue samples [66].

Cherry angiomas are often dome shaped, typically 0.1 to 0.4 cm in diameter, and do not usually blanch with pressure (picture 33A-B).

The diagnosis is based on the clinical appearance of the lesions. Examination with a dermatoscope shows characteristic red, purple, or blue-black lagoons (picture 34). (See "Dermoscopic evaluation of skin lesions", section on 'Criteria for hemangioma/angioma and angiokeratoma'.)

Cherry angiomas may be confused with amelanotic melanomas, which are usually friable lesions that may have recently changed in size or configuration (picture 35). If there is any concern for malignancy, the lesion should be excised and sent for histopathologic examination.

Treatment of cherry angiomas is only necessary for patients who are bothered by the lesions. Patients should be advised, however, that new lesions are likely to develop and there is no known way to prevent them.

The following modes of treatment may be used [67]:

Small lesions can be electrocauterized after local anesthesia with 1% lidocaine.

Shave excision and electrocauterization of the base is useful for larger lesions.

Laser therapy can also be used to remove superficial lesions. (See "Laser and light therapy for cutaneous vascular lesions".)

Cryotherapy.

Pyogenic granuloma — Pyogenic granuloma or lobular capillary hemangioma is a benign vascular tumor of the skin (picture 36A-D) or mucous membranes (picture 37) characterized by rapid growth and friable surface that bleeds profusely after minor trauma. Pyogenic granuloma occurs in patients of all ages, with a peak incidence in the second and third decade of life and during pregnancy. The cause of this is unknown. Reported trigger factors include trauma and medications.

Pyogenic granuloma is discussed in detail separately. (See "Pyogenic granuloma (lobular capillary hemangioma)".)

TUMORS OF SUBCUTANEOUS FAT

Lipoma — Superficial subcutaneous lipomas are the most common benign soft-tissue neoplasms. They consist of mature fat cells enclosed by thin fibrous capsules. Lipomas can occur on any part of the body and usually develop superficially in the subcutaneous tissue. Rarely, they may involve fascia or deeper muscular planes.

Lipomas present as soft, painless subcutaneous nodules ranging in size from 1 to >10 cm. They occur most frequently on the trunk and upper extremities and can be round, oval, or multilobulated (picture 23A-B). Frequently, patients may have more than one lipoma, and occasionally they may have a genetic condition (familial multiple lipomatosis) characterized by the development of multiple lipomas in several family members (picture 38). Malignant transformation of a lipoma into a liposarcoma is rare.

The diagnosis of lipoma is usually made clinically. Ultrasound examination can be helpful to distinguish a lipoma from an epidermoid cyst or a ganglion cyst [68]. If a suspected lipoma causes symptoms (pain or restriction of movement), is rapidly enlarging, or is firm rather than soft, a biopsy is indicated.

The treatment of lipomas, if needed because of pain, cosmesis, or concerns over diagnosis, is surgical removal of the fat cells and fibrous capsule. Recurrence of an excised lipoma is not common.

Side effects of surgery include scarring, seroma, and hematoma formation. In areas that are cosmetically sensitive, a surgical technique with segmental extraction and minimal surface incision may limit the scar size [69]. Alternative treatment modalities include liposuction and injection with low concentrations of deoxycholate [70,71]. Deoxycholate injections led to improvement in a small study of six patients [71,72]. However, further studies are necessary before this agent can be routinely recommended.

Angiolipoma — Angiolipoma is a benign tumor of adipocytes typically occurring in adolescents and young adults. Angiolipoma presents as a soft subcutaneous nodule of 0.5 to 2 cm in diameter, usually located on the forearm and chest wall (picture 39). Lesions are frequently multiple. Angiolipomas have been reported in HIV-infected individuals after starting antiretroviral therapy [73].

Clinically, angiolipomas closely resemble lipomas, although angiolipomas are usually painful and tender. Histopathologic examination is necessary for diagnosis. Macroscopically, angiolipoma appears as a small, well-circumscribed, subcutaneous tumor (picture 40); histology reveals a circumscribed, encapsulated tumor composed of an admixture of mature adipose cells and capillary vessels. Fibrin thrombi are typically seen. Occasionally, a predominance of blood vessels can be seen (cellular angiolipomas). The vascular proliferation component is not seen in lipomas.

Single, painful lesions can be excised. The treatment of multiple lesions is difficult. Liposuction has been used in a few cases [74,75].

GLOMUS TUMOR — Glomus tumor is a rare, benign neoplasm composed of cells resembling the modified smooth muscle cells of the normal glomus body [76]. It is usually located in areas of the skin that are rich in glomus bodies (eg, the subungual regions of digits or the deep dermis of the palm, wrist, forearm, and foot). Glomus tumors of the fingers and toes occur in approximately 5 percent of patients with neurofibromatosis type 1 (NF1) and are considered NF1-associated neoplasms [77-79].

Glomus tumor presents as a pink or purple vascular papule or nodule associated with paroxysmal pain, cold sensitivity, and tenderness. Subungual glomus tumors are particularly painful. Nail dystrophy and/or a bluish-red flush are typically seen (picture 41A-C).

The diagnosis is suspected on the basis of the clinical appearance and history of paroxysmal pain and cold sensitivity. Histopathologic examination of the excised tumor is necessary to confirm the diagnosis.

Histologically, glomus tumor is a well-circumscribed dermal nodule composed of glomus cells, vasculature, and smooth muscle cells (picture 42). Solid glomus tumor, with scarce vasculature and scant muscle component, is the most common variant [76]. Less common variants include glomangioma, with prominent vascular component, and glomangiomyoma, with prominent vascular and smooth muscle components.

Treatment is surgical excision. For subungual tumors, preoperative imaging studies with color Doppler ultrasonography and magnetic resonance may provide information on tumor size, shape, and precise anatomic location [80]. (See "Principles and overview of nail surgery", section on 'Glomus tumors'.)

PIGMENTED LESIONS

Melanocytic nevus — Melanocytic nevi (moles) are common neoplasms that result from the proliferation of cutaneous melanocytes. Nevi frequently present as pigmented macules, papules, or plaques but may also be skin colored or pink. (See "Acquired melanocytic nevi (moles)" and "Congenital melanocytic nevi".)

Solar lentigo — Solar lentigo, most commonly known as liver spots, "old age spots," or "sun spots," is a proliferation of normal melanocytes secondary to chronic solar damage. These lesions occur most commonly in individuals with a fair complexion who have a history of chronic sun exposure. Hyperpigmentation may vary from light to dark brown but is uniform within an individual lesion. (See "Benign pigmented skin lesions other than melanocytic nevi (moles)", section on 'Solar lentigo'.)

Diagnosis is based on the clinical appearance of flat, oval, evenly pigmented macules in areas of chronic sun exposure, particularly the face, dorsa of the hands, shoulders, and back (picture 43A-B). However, lesions that are reported to have changed color, variability in color, irregular margins, or developed a papular or nodular component should be biopsied to exclude malignancy.

The differential diagnosis of solar lentigines includes:

Seborrheic keratosis – Early, macular seborrheic keratoses may be difficult to differentiate from solar lentigines. Scale and palpable components are features of seborrheic keratoses. (See 'Seborrheic keratosis' above.)

Lentigo maligna – Lesions have variable pigmentation, irregular borders, and a history of gradual enlargement (picture 44A-C). (See "Lentigo maligna: Clinical manifestations, diagnosis, and management".)

Lentigo maligna melanoma – Lentigo maligna melanoma has an irregular border, variable pigmentation, and may have a raised papule or nodule within the plaque (picture 45A-B). The history is of gradual change, usually over years. (See "Lentigo maligna: Clinical manifestations, diagnosis, and management".)

No treatment is needed unless the patient desires removal for cosmetic reasons. Liquid nitrogen applied for 5 seconds or less can be used if treatment is desired. Lesions may heal with hypopigmentation.

Patients should be educated on the use of sunscreens and sun protection. Regular use of sunscreens prevents the development of solar lentigines, although it does not lead to regression of current lesions [81].

Hydroquinone cream 4% or triple combination cream with fluocinolone acetonide 0.01%, hydroquinone 4%, and tretinoin 0.05% plus sun protection can lighten existing lesions and reduce postinflammatory hyperpigmentation after cryotherapy [82]. Thin seborrheic keratoses, which are sometimes mistaken for lentigines, will not respond to topical hydroquinone.

Other — Other benign pigmented lesions, including café-au-lait spots, Becker nevus, and dermal melanocytosis, are discussed separately. (See "Benign pigmented skin lesions other than melanocytic nevi (moles)".)

OTHER BENIGN SKIN LESIONS

Chondrodermatitis nodularis helicis — Chondrodermatitis nodularis helicis (CNH) is a solitary, firm, painful nodule <10 mm in size, located on the helix or, less frequently, on the antihelix of the ear [83]. It is thought to result from cartilage inflammation that in extreme cases may cause cartilage necrosis and transepithelial elimination of degenerated collagen. Etiologic factors include chronic trauma, chronic sun exposure, low temperature, and prolonged or excessive pressure with compromise of local blood supply. An association with systemic diseases, including connective tissue and cardiovascular disease, also has been suggested [84].

CNH occurs most often in middle-aged or older men and is usually unilateral and typically develops on the same side the patient lies on in bed (picture 46) [83]. The nodule enlarges rapidly over a few months and then remains stable. The surface is frequently covered with a scale or crust that conceals a small ulcer. Pain is initiated by pressure or by changes in the ambient temperature and lasts from a few minutes to a few hours.

Diagnosis is based upon the clinical appearance and history of rapid development of a nodular lesion with associated pain and tenderness. If the diagnosis is in doubt, the lesion should be excised and sent for histopathologic examination. Histology shows a nodule of degenerated collagen surrounded by a lymphohistiocytic infiltrate; a central ulceration through which the degenerated collagen is extruded is often present. The differential diagnosis includes hypertrophic actinic keratosis, basal cell carcinoma (picture 47), keratoacanthoma (picture 48), squamous cell carcinoma (picture 49), and tophus (picture 50).

Conservative treatment includes strategies to relieve pressure and intralesional corticosteroids. Relieving pressure is the most important aspect of managing these lesions. The use of a donut-shaped pillow or foam padding for several weeks may provide resolution of symptoms [85-88]. Intralesional injection of triamcinolone acetonide 10 mg/mL may provide rapid pain relief in most patients and long-term resolution of CNH in some [89]. Monthly treatments may be necessary up to three to four treatments. Other treatments that have been evaluated in small numbers of patients include 2% topical nitroglycerin and photodynamic therapy [90-94].

Surgical approaches include cryotherapy, curettage, carbon dioxide laser ablation, wedge excision, and cartilage removal alone [95-100]. Recurrence after surgical excision has been reported in 10 to 30 percent of patients [87,101].

Venous lake — Venous lakes are lesions of dilated venous capillaries on the face, lips, and ears of older adult patients. The lesions bleed easily following minor trauma.

Diagnosis is based upon the appearance of the blue lesion in characteristic locations that disappear when compressed with a glass slide (picture 51). Venous lakes should be differentiated from blue nevi, which do not disappear with compression and do not usually appear on the face, ears, or lips. Nodular melanomas also can be confused with venous lakes, but do not disappear with compression, remaining a firm nodule.

Electrosurgery after anesthesia with 1% lidocaine can be used if the lesion causes a bleeding problem or is cosmetically unacceptable. Pulsed dye vascular laser may remove lesions without causing a scar [102].

Calluses and corns — Calluses and corns (clavi) are among the most frequent skin conditions and, by virtue of their location on the feet, may be the source of considerable disability, discomfort, and pain [103]:

Calluses are a diffuse thickening of the outermost layer of the skin, the stratum corneum, in response to repeated friction or pressure (picture 52).

Corns develop similarly, but differ by having a central "core" that is hyperkeratotic and often painful (picture 53A-B). Corns typically occur at pressure points secondary to ill-fitting shoes, an underlying bony spur, or an abnormal gait.

These lesions are typically located on the plantar aspect of prominent metatarsals, between toe clefts, or on the dorsal aspect of toe joints.

The diagnosis of calluses and corns is based upon their clinical appearance. They must be differentiated from plantar warts. After paring down, warts will have several dark specks that represent punctate capillary thromboses. Warts also disrupt normal skin markings so that the skin lines are no longer evident. Skin lines are more prominent in callosities.

Treatment of calluses and corns begins with prevention. Patients should be advised to avoid ill-fitting shoes. Consider referring patients with severe, recurrent problems for orthotic consultation to fit inner soles or metatarsal bars.

In most cases, calluses or corns can be treated conservatively with the application of keratolytics, such as salicylic acid (plasters or ointment) or urea-based creams. Scalpel debridement may be an alternative treatment to achieve a more rapid decrease of pain and improvement in function [104]. However, the long-term resolution of callus appears to be similar with both approaches [105]. Referral to podiatry to evaluate for an underlying bony abnormality should be considered for patients with lesions that are recalcitrant or recurrent:

Salicylic acid plaster – Salicylic acid plaster 40% is available without a prescription and is used as follows:

Debulk the callus or corn by paring skin with a no. 15 scalpel blade.

Cut the plaster to the size of the lesion and apply. Tape can be used to keep the patch in place and avoid it slipping onto unaffected areas.

Leave in place for 48 hours.

Pare down the remaining skin; replace the plaster patch and let the patient resume proper foot care and continue applying the patch at home.

Patients should be advised to remove the white, "dead" skin with a metal nail file or pumice stone each night before replacing the patch. Soaking the skin in warm water for five minutes before using a nail file or pumice stone can help in removing the "dead" skin.

Use of the patch should stop once the lesion has resolved.

Follow-up if lesions do not resolve within one to two weeks.

Do not use plaster in patients with peripheral neuropathies. These patients may not notice pain with improper patch placement and can develop damage to normal skin.

Salicylic acid ointment – Salicylic acid 10 to 20% in petrolatum (available in 30 to 45 g tubes) is available by prescription and compounded by a pharmacist. The ointment is applied in a small amount on the callus under occlusion nightly. Patients with peripheral neuropathies should not use salicylic acid ointments.

Urea-based creams – Creams containing 40% urea, especially under occlusion overnight, can assist with callus removal similarly to salicylic acid. High-concentration urea creams should be used under medical supervision in patients with peripheral neuropathies and diminished sensation in the feet.

INFORMATION FOR PATIENTS — UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5th to 6th grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10th to 12th grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.

Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)

Basics topics (see "Patient education: Skin tags (acrochordon) (The Basics)" and "Patient education: Seborrheic keratosis (The Basics)" and "Patient education: Corns and calluses (The Basics)")

SUMMARY

Diagnostic approach – Most benign skin lesions are diagnosed on the basis of clinical appearance (morphology, distribution) and history (see "Approach to the clinical dermatologic diagnosis"). Dermoscopy, a skin examination technique performed with a handheld instrument called a dermatoscope, is a helpful adjunct to the clinical examination of a variety of pigmented and nonpigmented lesions (see "Dermoscopic evaluation of skin lesions"). If the diagnosis of a lesion is uncertain or if a lesion has exhibited unexpected changes in appearance or symptoms, a diagnostic procedure (eg, biopsy, excision) is indicated to confirm the diagnosis. (See "Skin biopsy techniques".)

Dermal tumors – Common dermal tumors include acrochordon (skin tag (picture 1A-F)), dermatofibroma (picture 4A-C), and cutaneous neurofibroma (picture 2). (See 'Dermal tumors' above.)

Epidermal tumors – Common benign epidermal (keratinocyte) tumors include seborrheic keratosis (picture 10A-B, 10G) and dermatosis papulosa nigra. (See 'Seborrheic keratosis' above.)

Adnexal tumors – Benign adnexal (appendageal) tumors, including sebaceous hyperplasia (picture 17E), poroma (picture 17A), and pilomatricoma (picture 17B), are discussed separately. (See "Cutaneous adnexal tumors".)

Cysts – Cutaneous cysts include milium, epidermoid cyst (picture 54A-B), pilar cyst (picture 27A, 27C), vellus hair cyst (picture 28), and digital myxoid cyst (picture 31). Mucocele is a common cystic lesion most frequently found in the lower lip mucosa (picture 30). (See 'Cysts' above.)

Vascular tumors – Benign vascular tumors include infantile hemangioma (picture 32), pyogenic granuloma (picture 36A-D), and cherry hemangioma (picture 33A-B) (see 'Vascular tumors' above). Infantile hemangioma and pyogenic granuloma are discussed in separate topic reviews. (See "Infantile hemangiomas: Epidemiology, pathogenesis, clinical features, and complications" and "Pyogenic granuloma (lobular capillary hemangioma)".)

Tumors of subcutaneous fat – Common tumors of subcutaneous fat include lipoma (picture 23A) and angiolipoma (picture 39). (See 'Tumors of subcutaneous fat' above.)

Glomus tumor – Glomus tumor (picture 41A-C) is a rare tumor typically located in the subungual regions of digits. (See 'Glomus tumor' above.)

Pigmented lesions – Common benign pigmented lesions include acquired and congenital melanocytic nevi and solar lentigines (picture 43A-B). These and other pigmented lesions are discussed in separate topic reviews. (See "Acquired melanocytic nevi (moles)" and "Congenital melanocytic nevi" and "Benign pigmented skin lesions other than melanocytic nevi (moles)".)

ACKNOWLEDGMENT — The UpToDate editorial staff acknowledges Beth G Goldstein, MD, who contributed to an earlier version of this topic review.

  1. Banik R, Lubach D. Skin tags: localization and frequencies according to sex and age. Dermatologica 1987; 174:180.
  2. Boza JC, Trindade EN, Peruzzo J, et al. Skin manifestations of obesity: a comparative study. J Eur Acad Dermatol Venereol 2012; 26:1220.
  3. Ragunatha S, Anitha B, Inamadar AC, et al. Cutaneous disorders in 500 diabetic patients attending diabetic clinic. Indian J Dermatol 2011; 56:160.
  4. Senel E, Salmanoğlu M, Solmazgül E, Berçik İnal B. Acrochordons as a cutaneous sign of impaired carbohydrate metabolism, hyperlipidemia, liver enzyme abnormalities and hypertension: a case-control study. J Eur Acad Dermatol Venereol 2011.
  5. Shah R, Jindal A, Patel N. Acrochordons as a cutaneous sign of metabolic syndrome: a case-control study. Ann Med Health Sci Res 2014; 4:202.
  6. Akpinar F, Dervis E. Association between acrochordons and the components of metabolic syndrome. Eur J Dermatol 2012; 22:106.
  7. Winton GB, Lewis CW. Dermatoses of pregnancy. J Am Acad Dermatol 1982; 6:977.
  8. Peyrin-Biroulet L, Loftus EV Jr, Tremaine WJ, et al. Perianal Crohn's disease findings other than fistulas in a population-based cohort. Inflamm Bowel Dis 2012; 18:43.
  9. Toro JR, Wei MH, Glenn GM, et al. BHD mutations, clinical and molecular genetic investigations of Birt-Hogg-Dubé syndrome: a new series of 50 families and a review of published reports. J Med Genet 2008; 45:321.
  10. Palm MD, Altman JS. Topical hemostatic agents: a review. Dermatol Surg 2008; 34:431.
  11. Pusztaszeri M, Jaquet PY, Williamson C. Giant hemosiderotic dermatofibroma: a case report and review of the literature. Case Rep Dermatol 2011; 3:32.
  12. Requena L, Fariña MC, Fuente C, et al. Giant dermatofibroma. A little-known clinical variant of dermatofibroma. J Am Acad Dermatol 1994; 30:714.
  13. Beatrous SV, Riahi RR, Grisoli SB, Cohen PR. Associated conditions in patients with multiple dermatofibromas: Case reports and literature review. Dermatol Online J 2017; 23.
  14. Zaccaria E, Rebora A, Rongioletti F. Multiple eruptive dermatofibromas and immunosuppression: report of two cases and review of the literature. Int J Dermatol 2008; 47:723.
  15. Queirós C, Uva L, Soares de Almeida L, Filipe P. Multiple eruptive dermatofibromas associated with pregnancy- a case and literature review. Dermatol Online J 2019; 25.
  16. Supsrisunjai C, Hsu CK, Michael M, et al. Coagulation Factor XIII-A Subunit Missense Mutation in the Pathobiology of Autosomal Dominant Multiple Dermatofibromas. J Invest Dermatol 2020; 140:624.
  17. Mentzel T. Cutaneous mesenchymal tumours: an update. Pathology 2014; 46:149.
  18. Doyle LA, Fletcher CD. Metastasizing "benign" cutaneous fibrous histiocytoma: a clinicopathologic analysis of 16 cases. Am J Surg Pathol 2013; 37:484.
  19. Gershtenson PC, Krunic AL, Chen HM. Multiple clustered dermatofibroma: case report and review of the literature. J Cutan Pathol 2010; 37:e42.
  20. Finch J, Berke A, McCusker M, Chang MW. Congenital multiple clustered dermatofibroma in a 12-year-old girl. Pediatr Dermatol 2014; 31:105.
  21. Kaddu S, McMenamin ME, Fletcher CD. Atypical fibrous histiocytoma of the skin: clinicopathologic analysis of 59 cases with evidence of infrequent metastasis. Am J Surg Pathol 2002; 26:35.
  22. Luzar B, Calonje E. Cutaneous fibrohistiocytic tumours - an update. Histopathology 2010; 56:148.
  23. Gaufin M, Michaelis T, Duffy K. Cellular Dermatofibroma: Clinicopathologic Review of 218 Cases of Cellular Dermatofibroma to Determine the Clinical Recurrence Rate. Dermatol Surg 2019; 45:1359.
  24. Alves JV, Matos DM, Barreiros HF, Bártolo EA. Variants of dermatofibroma--a histopathological study. An Bras Dermatol 2014; 89:472.
  25. Lanigan SW, Robinson TW. Cryotherapy for dermatofibromas. Clin Exp Dermatol 1987; 12:121.
  26. Hafner C, Vogt T. Seborrheic keratosis. J Dtsch Dermatol Ges 2008; 6:664.
  27. Li YH, Chen G, Dong XP, Chen HD. Detection of epidermodysplasia verruciformis-associated human papillomavirus DNA in nongenital seborrhoeic keratosis. Br J Dermatol 2004; 151:1060.
  28. Duperret EK, Oh SJ, McNeal A, et al. Activating FGFR3 mutations cause mild hyperplasia in human skin, but are insufficient to drive benign or malignant skin tumors. Cell Cycle 2014; 13:1551.
  29. Logié A, Dunois-Lardé C, Rosty C, et al. Activating mutations of the tyrosine kinase receptor FGFR3 are associated with benign skin tumors in mice and humans. Hum Mol Genet 2005; 14:1153.
  30. Hafner C, Hartmann A, Real FX, et al. Spectrum of FGFR3 mutations in multiple intraindividual seborrheic keratoses. J Invest Dermatol 2007; 127:1883.
  31. Hafner C, López-Knowles E, Luis NM, et al. Oncogenic PIK3CA mutations occur in epidermal nevi and seborrheic keratoses with a characteristic mutation pattern. Proc Natl Acad Sci U S A 2007; 104:13450.
  32. Chu CY, Yang CH, Chiu HC. Inflammation of seborrheic keratoses due to docetaxel treatment. Acta Derm Venereol 2001; 81:316.
  33. Patton T, Zirwas M, Nieland-Fisher N, Jukic D. Inflammation of seborrheic keratoses caused by cytarabine: a pseudo sign of Leser-Trelat. J Drugs Dermatol 2004; 3:565.
  34. Cascajo CD, Reichel M, Sánchez JL. Malignant neoplasms associated with seborrheic keratoses. An analysis of 54 cases. Am J Dermatopathol 1996; 18:278.
  35. Jee H, Lee NR, Ahn SK. Case of seborrheic keratosis with underlying basal cell carcinoma suggesting a collision tumor. J Dermatol 2013; 40:837.
  36. Defazio J, Zalaudek I, Busam KJ, et al. Association between melanocytic neoplasms and seborrheic keratosis: more than a coincidental collision? Dermatol Pract Concept 2012; 2:202a09.
  37. Birnie AJ, Varma S. A dermatoscopically diagnosed collision tumour: malignant melanoma arising within a seborrhoeic keratosis. Clin Exp Dermatol 2008; 33:512.
  38. Lim C. Seborrhoeic keratoses with associated lesions: a retrospective analysis of 85 lesions. Australas J Dermatol 2006; 47:109.
  39. Longo C, Moscarella E, Piana S, et al. Not all lesions with a verrucous surface are seborrheic keratoses. J Am Acad Dermatol 2014; 70:e121.
  40. Kim YK, Kim DY, Lee SJ, et al. Therapeutic efficacy of long-pulsed 755-nm alexandrite laser for seborrheic keratoses. J Eur Acad Dermatol Venereol 2014; 28:1007.
  41. Polder KD, Landau JM, Vergilis-Kalner IJ, et al. Laser eradication of pigmented lesions: a review. Dermatol Surg 2011; 37:572.
  42. Culbertson GR. 532-nm diode laser treatment of seborrheic keratoses with color enhancement. Dermatol Surg 2008; 34:525.
  43. Wood LD, Stucki JK, Hollenbeak CS, Miller JJ. Effectiveness of cryosurgery vs curettage in the treatment of seborrheic keratoses. JAMA Dermatol 2013; 149:108.
  44. Grimes PE, Arora S, Minus HR, Kenney JA Jr. Dermatosis papulosa nigra. Cutis 1983; 32:385.
  45. Garcia MS, Azari R, Eisen DB. Treatment of dermatosis papulosa nigra in 10 patients: a comparison trial of electrodesiccation, pulsed dye laser, and curettage. Dermatol Surg 2010; 36:1968.
  46. Taylor SC, Averyhart AN, Heath CR. Postprocedural wound-healing efficacy following removal of dermatosis papulosa nigra lesions in an African American population: a comparison of a skin protectant ointment and a topical antibiotic. J Am Acad Dermatol 2011; 64:S30.
  47. Lee JH, Kwon HS, Jung HM, et al. Wood's lamp-induced fluorescence of milia. J Am Acad Dermatol 2018; 78:e99.
  48. Shin D, Seo J, Kim SM, Kim DY. Multiple milia formation induced by dovitinib. J Dermatol 2015; 42:411.
  49. Connelly T. Eruptive milia and rapid response to topical tretinoin. Arch Dermatol 2008; 144:816.
  50. Nambudiri VE, Habib N, Arndt KA, Kane KS. Milia en plaque of the nose: report of a case and successful treatment with topical tretinoin. Pediatrics 2014; 133:e1373.
  51. Mehrabi D, Leonhardt JM, Brodell RT. Removal of keratinous and pilar cysts with the punch incision technique: analysis of surgical outcomes. Dermatol Surg 2002; 28:673.
  52. Lee HE, Yang CH, Chen CH, et al. Comparison of the surgical outcomes of punch incision and elliptical excision in treating epidermal inclusion cysts: a prospective, randomized study. Dermatol Surg 2006; 32:520.
  53. Zuber TJ. Minimal excision technique for epidermoid (sebaceous) cysts. Am Fam Physician 2002; 65:1409.
  54. Klin B, Ashkenazi H. Sebaceous cyst excision with minimal surgery. Am Fam Physician 1990; 41:1746.
  55. Seidenari S, Pellacani G, Nasti S, et al. Hereditary trichilemmal cysts: a proposal for the assessment of diagnostic clinical criteria. Clin Genet 2013; 84:65.
  56. Hörer S, Marrakchi S, Radner FPW, et al. A Monoallelic Two-Hit Mechanism in PLCD1 Explains the Genetic Pathogenesis of Hereditary Trichilemmal Cyst Formation. J Invest Dermatol 2019; 139:2154.
  57. Torchia D, Vega J, Schachner LA. Eruptive vellus hair cysts: a systematic review. Am J Clin Dermatol 2012; 13:19.
  58. Saks K, Levitt JO. Tazarotene 0.1 percent cream fares better than erbium:YAG laser or incision and drainage in a patient with eruptive vellus hair cysts. Dermatol Online J 2006; 12:7.
  59. Kaya TI, Tataroglu C, Tursen U, Ikizoglu G. Eruptive vellus hair cysts: an effective extraction technique for treatment and diagnosis. J Eur Acad Dermatol Venereol 2006; 20:264.
  60. Fernández-Torres R, Del Pozo J, Castiñeiras I, et al. Treatment of multiple eruptive vellus hair cysts with carbon dioxide laser vaporization and manual lateral pressure. Clin Exp Dermatol 2009; 34:e716.
  61. Gordon Spratt EA, Kaplan J, Patel RR, et al. Steatocystoma. Dermatol Online J 2013; 19:20721.
  62. Covello SP, Smith FJ, Sillevis Smitt JH, et al. Keratin 17 mutations cause either steatocystoma multiplex or pachyonychia congenita type 2. Br J Dermatol 1998; 139:475.
  63. Bakkour W, Madan V. Carbon dioxide laser perforation and extirpation of steatocystoma multiplex. Dermatol Surg 2014; 40:658.
  64. Rossi R, Cappugi P, Battini M, et al. CO2 laser therapy in a case of steatocystoma multiplex with prominent nodules on the face and neck. Int J Dermatol 2003; 42:302.
  65. Choudhary S, Koley S, Salodkar A. A modified surgical technique for steatocystoma multiplex. J Cutan Aesthet Surg 2010; 3:25.
  66. Klebanov N, Lin WM, Artomov M, et al. Use of Targeted Next-Generation Sequencing to Identify Activating Hot Spot Mutations in Cherry Angiomas. JAMA Dermatol 2019; 155:211.
  67. Buslach N, Foulad DP, Saedi N, Mesinkovska NA. Treatment Modalities for Cherry Angiomas: A Systematic Review. Dermatol Surg 2020; 46:1691.
  68. Rahmani G, McCarthy P, Bergin D. The diagnostic accuracy of ultrasonography for soft tissue lipomas: a systematic review. Acta Radiol Open 2017; 6:2058460117716704.
  69. Chandawarkar RY, Rodriguez P, Roussalis J, Tantri MD. Minimal-scar segmental extraction of lipomas: study of 122 consecutive procedures. Dermatol Surg 2005; 31:59.
  70. Wilhelmi BJ, Blackwell SJ, Mancoll JS, Phillips LG. Another indication for liposuction: small facial lipomas. Plast Reconstr Surg 1999; 103:1864.
  71. Rotunda AM, Ablon G, Kolodney MS. Lipomas treated with subcutaneous deoxycholate injections. J Am Acad Dermatol 2005; 53:973.
  72. Amber KT, Ovadia S, Camacho I. Injection therapy for the management of superficial subcutaneous lipomas. J Clin Aesthet Dermatol 2014; 7:46.
  73. Dank JP, Colven R. Protease inhibitor-associated angiolipomatosis. J Am Acad Dermatol 2000; 42:129.
  74. Kaneko T, Tokushige H, Kimura N, et al. The treatment of multiple angiolipomas by liposuction surgery. J Dermatol Surg Oncol 1994; 20:690.
  75. Kanter WR, Wolfort FG. Multiple familial angiolipomatosis: treatment of liposuction. Ann Plast Surg 1988; 20:277.
  76. Gombos Z, Zhang PJ. Glomus tumor. Arch Pathol Lab Med 2008; 132:1448.
  77. Brems H, Park C, Maertens O, et al. Glomus tumors in neurofibromatosis type 1: genetic, functional, and clinical evidence of a novel association. Cancer Res 2009; 69:7393.
  78. Stewart DR, Sloan JL, Yao L, et al. Diagnosis, management, and complications of glomus tumours of the digits in neurofibromatosis type 1. J Med Genet 2010; 47:525.
  79. Kumar MG, Emnett RJ, Bayliss SJ, Gutmann DH. Glomus tumors in individuals with neurofibromatosis type 1. J Am Acad Dermatol 2014; 71:44.
  80. Baek HJ, Lee SJ, Cho KH, et al. Subungual tumors: clinicopathologic correlation with US and MR imaging findings. Radiographics 2010; 30:1621.
  81. Thompson SC, Jolley D, Marks R. Reduction of solar keratoses by regular sunscreen use. N Engl J Med 1993; 329:1147.
  82. Hexsel D, Hexsel C, Porto MD, Siega C. Triple combination as adjuvant to cryotherapy in the treatment of solar lentigines: investigator-blinded, randomized clinical trial. J Eur Acad Dermatol Venereol 2015; 29:128.
  83. Wagner G, Liefeith J, Sachse MM. Clinical appearance, differential diagnoses and therapeutical options of chondrodermatitis nodularis chronica helicis Winkler. J Dtsch Dermatol Ges 2011; 9:287.
  84. Magro CM, Dyrsen ME. The use of C3d and C4d immunohistochemistry on formalin-fixed tissue as a diagnostic adjunct in the assessment of inflammatory skin disease. J Am Acad Dermatol 2008; 59:822.
  85. Kuen-Spiegl M, Ratzinger G, Sepp N, Fritsch P. Chondrodermatitis nodularis chronica helicis - a conservative therapeutic approach by decompression. J Dtsch Dermatol Ges 2011; 9:292.
  86. Sanu A, Koppana R, Snow DG. Management of chondrodermatitis nodularis chronica helicis using a 'doughnut pillow'. J Laryngol Otol 2007; 121:1096.
  87. Moncrieff M, Sassoon EM. Effective treatment of chondrodermatitis nodularis chronica helicis using a conservative approach. Br J Dermatol 2004; 150:892.
  88. Timoney N, Davison PM. Management of chondrodermatitis helicis by protective padding: a series of 12 cases and a review of the literature. Br J Plast Surg 2002; 55:387.
  89. Cox NH, Denham PF. Intralesional triamcinolone for chondrodermatitis nodularis: a follow-up study of 60 patients. Br J Dermatol 2002; 146:712.
  90. Gilaberte Y, Frias MP, Pérez-Lorenz JB. Chondrodermatitis nodularis helicis successfully treated with photodynamic therapy. Arch Dermatol 2010; 146:1080.
  91. Pellegrino M, Taddeucci P, Mei S, et al. Chondrodermatitis nodularis chronica helicis and photodynamic therapy: a new therapeutic option? Dermatol Ther 2011; 24:144.
  92. Flynn V, Chisholm C, Grimwood R. Topical nitroglycerin: a promising treatment option for chondrodermatitis nodularis helicis. J Am Acad Dermatol 2011; 65:531.
  93. Garrido Colmenero C, Martínez García E, Blasco Morente G, Tercedor Sánchez J. Nitroglycerin patch for the treatment of chondrodermatitis nodularis helicis: a new therapeutic option. Dermatol Ther 2014; 27:278.
  94. Kechichian E, Jabbour S, Haber R, et al. Management of Chondrodermatitis Nodularis Helicis: A Systematic Review and Treatment Algorithm. Dermatol Surg 2016; 42:1125.
  95. Lawrence CM. The treatment of chondrodermatitis nodularis with cartilage removal alone. Arch Dermatol 1991; 127:530.
  96. de Ru JA, Lohuis PJ, Saleh HA, Vuyk HD. Treatment of chondrodermatitis nodularis with removal of the underlying cartilage alone: retrospective analysis of experience in 37 lesions. J Laryngol Otol 2002; 116:677.
  97. Taylor MB. Chondrodermatitis nodularis chronica helicis. Successful treatment with the carbon dioxide laser. J Dermatol Surg Oncol 1991; 17:862.
  98. Coldiron BM. The surgical management of chondrodermatitis nodularis chronica helicis. J Dermatol Surg Oncol 1991; 17:902.
  99. Kromann N, Høyer H, Reymann F. Chondrodermatitis nodularis chronica helicis treated with curettage and electrocauterization: follow-up of a 15-year material. Acta Derm Venereol 1983; 63:85.
  100. Hussain W, Chalmers RJ. Simplified surgical treatment of chondrodermatitis nodularis by cartilage trimming and sutureless skin closure. Br J Dermatol 2009; 160:116.
  101. Feldman AL, Manstein CH, Manstein ME, Czulewicz A. Chondrodermatitis nodularis auricularis: a new name for an old disease. Plast Reconstr Surg 2009; 123:25e.
  102. Jay H, Borek C. Treatment of a venous-lake angioma with intense pulsed light. Lancet 1998; 351:112.
  103. Freeman DB. Corns and calluses resulting from mechanical hyperkeratosis. Am Fam Physician 2002; 65:2277.
  104. Gijón-Noguerón G, García-Paya I, Morales-Asencio JM, et al. Short-term effect of scalpel debridement of plantar callosities versus treatment with salicylic acid patches: The EMEDESCA randomized controlled trial. J Dermatol 2017; 44:706.
  105. Stephenson J, Farndon L, Concannon M. Analysis of a trial assessing the long-term effectiveness of salicylic acid plasters compared with scalpel debridement in facilitating corn resolution in patients with multiple corns. J Dermatol 2016; 43:662.
Topic 5573 Version 48.0

References